FR2525602A1
(fr)
*
|
1982-04-21 |
1983-10-28 |
Synthelabo |
Imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
|
FR2525601A1
(fr)
*
|
1982-04-21 |
1983-10-28 |
Synthelabo |
Derives d'imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
|
FR2568879B1
(fr)
*
|
1984-08-07 |
1986-12-12 |
Synthelabo |
Imidazo(1,2-a)quinolines, leur preparation et leur application en therapeutique
|
FR2581646B1
(fr)
*
|
1985-05-07 |
1987-09-18 |
Synthelabo |
Derives d'imidazopyridine, leur preparation et leur application en therapeutique
|
FR2593179B1
(fr)
*
|
1986-01-22 |
1988-04-01 |
Synthelabo |
Derives d'imidazo(1,2-a)quinoleines, leur preparation et leur application en therapeutique
|
ES2032455T3
(es)
*
|
1986-01-22 |
1993-02-16 |
Synthelabo |
Procedimiento para preparar derivados de 3-acilaminometil-imidazo (-1,2-a)piridinas.
|
FR2593817B1
(fr)
*
|
1986-01-31 |
1988-04-15 |
Synthelabo |
Derives de tetrahydro-5,6,7,8 imidazo(1,2-a)pyridine, leur preparation et leur application en therapeutique
|
FR2599368B1
(fr)
*
|
1986-06-02 |
1988-08-05 |
Synthelabo |
Derives hydroxyles d'imidazopyridines, leur preparation et leur application en therapeutique
|
FR2600650B1
(fr)
*
|
1986-06-27 |
1988-09-09 |
Synthelabo |
Procede de preparation d'imidazopyridines et composes intermediaires
|
FR2606409B1
(fr)
*
|
1986-11-07 |
1989-05-05 |
Synthelabo |
Derives d'imidazopyridine, leur preparation et leur application en therapeutique
|
FR2606411B1
(fr)
*
|
1986-11-07 |
1989-04-07 |
Synthelabo |
Imidazopyridine-acetamides, leur preparation et leur application en therapeutique
|
FR2606410B1
(fr)
*
|
1986-11-07 |
1989-02-24 |
Synthelabo |
Imidazopyridines, leur preparation et leur application en therapeutique
|
ES2026666T3
(es)
*
|
1987-03-27 |
1992-05-01 |
Synthelabo |
Procedimiento para preparar derivados de imidazopiridinas.
|
FR2612928B1
(fr)
*
|
1987-03-27 |
1989-06-16 |
Synthelabo |
Derives hydroxyles d'imidazopyridines, leur preparation et leur application en therapeutique
|
FR2612927B1
(fr)
*
|
1987-03-27 |
1989-06-09 |
Synthelabo |
Derives d'imidazopyridines, leur preparation et leur application en therapeutique
|
US5032595A
(en)
*
|
1989-11-24 |
1991-07-16 |
Fidia-Georgetown Institute For The Neurosciences |
Method of stimulating steroidogenesis with alpidem
|
EP0809642A1
(en)
*
|
1995-02-15 |
1997-12-03 |
PHARMACIA & UPJOHN COMPANY |
Imidazo 1,2-a]pyridines for the treatment of cns and cardiac diseases
|
IT1276522B1
(it)
*
|
1995-04-07 |
1997-10-31 |
Elena Benincasa |
Uso dello zolpidem per il trattamento terapeudico di sindromi neuropsichiatriche associate a disfunsione e di circuiti neurali dei
|
US6013654A
(en)
*
|
1997-08-14 |
2000-01-11 |
Pharmacia & Upjohn Company |
Imidazo[1,2-A]pyridines for the treatment of CNS and cardiac diseases
|
AUPP278498A0
(en)
|
1998-04-03 |
1998-04-30 |
Australian Nuclear Science & Technology Organisation |
Peripheral benzodiazepine receptor binding agents
|
EP1005863A1
(en)
*
|
1998-12-04 |
2000-06-07 |
Synthelabo |
Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
|
DK1038875T3
(da)
|
1999-03-25 |
2003-09-29 |
Synthon Bv |
Imidazopyridine- derivativer og fremgangsmåde til fremstilling deraf
|
ATE297924T1
(de)
*
|
1999-03-25 |
2005-07-15 |
Synthon Bv |
Zolpidem salze
|
US6333345B1
(en)
|
1999-05-14 |
2001-12-25 |
Sepracor, Inc. |
Methods of using and compositions comprising N-desmethylzolpidem
|
US6399621B1
(en)
|
1999-08-10 |
2002-06-04 |
American Cyanamid Company |
N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
|
US20030091632A1
(en)
*
|
1999-08-26 |
2003-05-15 |
Neurocrine Biosciences, Inc. |
Controlled-release sedative-hypnotic compositions and methods related thereto
|
US6485746B1
(en)
|
2000-08-25 |
2002-11-26 |
Neurocrine Biosciences, Inc. |
Controlled-release sedative-hypnotic compositions and methods related thereto
|
US6384221B1
(en)
*
|
1999-09-02 |
2002-05-07 |
Neurocrine Biosciences, Inc. |
Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
|
WO2001078725A2
(en)
*
|
2000-04-13 |
2001-10-25 |
Synthon B.V. |
Modified release formulations containing a hypnotic agent
|
DE20122435U1
(de)
*
|
2000-04-24 |
2005-10-06 |
Teva Pharmaceutical Industries Ltd. |
Mikronisiertes Zolpidem-Hemitartrat
|
EP1604663A1
(en)
|
2000-04-24 |
2005-12-14 |
Teva Pharmaceutical Industries Ltd |
Zolpidem Hemitartrate Form H Solvate
|
WO2001092257A1
(en)
*
|
2000-05-26 |
2001-12-06 |
Neurogen Corporation |
Oxo-imidazopyrimidine-carboxamides and their use as gaba brain receptor ligands
|
AU2001270297A1
(en)
*
|
2000-06-30 |
2002-01-14 |
Neurogen Corporation |
2-phenylimidazo(1,2-a)pyridine derivatives: a new class of gaba brain receptor ligands
|
IT1318624B1
(it)
|
2000-07-14 |
2003-08-27 |
Dinamite Dipharma S P A In For |
Processo per la preparazione di 2-fenil-imidazo (1,2-a)piridin-3-acetammidi.
|
DE10040016A1
(de)
*
|
2000-08-16 |
2002-02-28 |
Boehringer Ingelheim Pharma |
Neue beta-Amyloid Inhibitoren, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
US6514969B2
(en)
*
|
2000-08-16 |
2003-02-04 |
Boehringer Ingelheim Pharma Kg |
β-amyloid inhibitors, processes for preparing them, and their use in pharmaceutical compositions
|
AU2000264428A1
(en)
*
|
2000-08-17 |
2002-02-25 |
Cilag A.G. |
Process for the preparation of imidazopyridines
|
AU2001284322A1
(en)
*
|
2000-08-29 |
2002-03-13 |
Ranbaxy Laboratories Limited |
Synthesis of n,n-dimethyl-3-(4-methyl) benzoyl propionamide, a key intermediate of zolpidem
|
US6596731B2
(en)
|
2001-03-27 |
2003-07-22 |
Hoffmann-La Roche Inc. |
Substituted imidazo[1,2-A] pyridine derivatives
|
DE10117183A1
(de)
*
|
2001-04-05 |
2002-10-10 |
Gruenenthal Gmbh |
Verwendung von substituierten Imidazo[1,2-a]-pyridinverbindungen als Arzneimittel
|
KR100433502B1
(ko)
*
|
2001-10-10 |
2004-06-07 |
철 양 |
확장부가 형성된 종이컵
|
DE10247271A1
(de)
*
|
2002-10-10 |
2004-08-26 |
Grünenthal GmbH |
Substituierte C-Imidazo[1,2-a]pyridin-3-yle
|
DE60326270D1
(de)
*
|
2002-12-18 |
2009-04-02 |
Mallinckrodt Inc |
Synthese von heteroaryl acetamiden
|
WO2004066930A2
(en)
*
|
2003-01-27 |
2004-08-12 |
Arthur Zaks |
Method for inducing pain relief using imidazo[1,2-a]pyridine derivatives
|
US20040241100A1
(en)
*
|
2003-03-17 |
2004-12-02 |
Fabre Kramer Pharmaceutical, Inc. |
Nasally administrable compositions of zolpidem and methods of use
|
WO2005010002A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Ranbaxy Laboratories Limited |
Process for the synthesis of zolpidem
|
AU2004287847A1
(en)
*
|
2003-10-28 |
2005-05-19 |
Sepracor Inc. |
Imidazo(1,2-a)pyridine anxiolytics
|
EP2343073A3
(en)
|
2003-12-11 |
2011-10-12 |
Sepracor Inc. |
Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
|
JP5179757B2
(ja)
*
|
2004-02-17 |
2013-04-10 |
トランセプト ファーマシューティカルズ, インコーポレイティド |
口腔粘膜を介して催眠剤をデリバリーするための組成物及びその使用方法
|
AU2005215376B2
(en)
|
2004-02-18 |
2011-01-20 |
Sunovion Pharmaceuticals Inc. |
Dopamine-agonist combination therapy with sedatives for improving sleep quality
|
WO2006008636A2
(en)
*
|
2004-07-16 |
2006-01-26 |
Ranbaxy Laboratories Limited |
Processes for the preparation of zolpidem and its hemitartrate
|
US20060084806A1
(en)
*
|
2004-07-21 |
2006-04-20 |
Ramasubramanian Sridharan |
Processes for the preparation of imidazo[1,2-a] pyridine derivatives
|
FR2874611B1
(fr)
*
|
2004-08-31 |
2006-11-17 |
Servier Lab |
Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
US8242131B2
(en)
*
|
2005-05-25 |
2012-08-14 |
Transcept Pharmaceuticals, Inc. |
Methods of treating middle-of-the-night insomnia
|
US20070287740A1
(en)
*
|
2005-05-25 |
2007-12-13 |
Transcept Pharmaceuticals, Inc. |
Compositions and methods of treating middle-of-the night insomnia
|
US20070225322A1
(en)
*
|
2005-05-25 |
2007-09-27 |
Transoral Pharmaceuticals, Inc. |
Compositions and methods for treating middle-of-the night insomnia
|
US20070020333A1
(en)
*
|
2005-07-20 |
2007-01-25 |
Chin-Chih Chiang |
Controlled release of hypnotic agents
|
EP2275095A3
(en)
|
2005-08-26 |
2011-08-17 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation
|
EP2258358A3
(en)
|
2005-08-26 |
2011-09-07 |
Braincells, Inc. |
Neurogenesis with acetylcholinesterase inhibitor
|
JP2009512711A
(ja)
|
2005-10-21 |
2009-03-26 |
ブレインセルス,インコーポレイティド |
Pde阻害による神経新生の調節
|
CA2625210A1
(en)
|
2005-10-31 |
2007-05-10 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
KR101345468B1
(ko)
|
2005-11-18 |
2013-12-30 |
신톤 비.브이. |
졸피뎀 정제
|
EP1803722A1
(en)
|
2006-01-03 |
2007-07-04 |
Ferrer Internacional, S.A. |
Imidazo[1,2-a]pyridin-3-yl-acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof
|
US8309104B2
(en)
|
2006-03-02 |
2012-11-13 |
Watson Pharmaceuticals, Inc. |
Oral controlled release formulation for sedative and hypnotic agents
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
EP1845098A1
(en)
*
|
2006-03-29 |
2007-10-17 |
Ferrer Internacional, S.A. |
Imidazo[1,2-b]pyridazines, their processes of preparation and their use as GABA receptor ligands
|
WO2007134136A2
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
AU2007249435A1
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
5 HT receptor mediated neurogenesis
|
WO2007143468A2
(en)
*
|
2006-06-05 |
2007-12-13 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted imidazopyridine compounds with hypnotic effects
|
EP2752415B8
(en)
*
|
2006-08-24 |
2017-11-15 |
Australian Nuclear Science & Technology Organisation |
Fluorinated ligands for targeting peripheral benzodiazepine receptors
|
KR20090064418A
(ko)
|
2006-09-08 |
2009-06-18 |
브레인셀즈 인코퍼레이션 |
4-아실아미노피리딘 유도체 포함 조합물
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
US20080145425A1
(en)
*
|
2006-12-15 |
2008-06-19 |
Pliva Research & Development Limited |
Pharmaceutical composition of zolpidem
|
US20090076066A1
(en)
*
|
2007-09-19 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched zolpidem
|
CN101903381A
(zh)
*
|
2007-10-24 |
2010-12-01 |
日本医事物理股份有限公司 |
对淀粉样蛋白具有亲和性的新化合物
|
WO2009085310A1
(en)
*
|
2007-12-26 |
2009-07-09 |
Teva Pharmaceutical Industries Ltd. |
Extended-release pharmaceutical compositions containing zolpidem
|
JP2012500225A
(ja)
*
|
2008-08-19 |
2012-01-05 |
ザ ユニバーシティ オブ シドニー |
新規な化合物および診断におけるその使用
|
US10478438B2
(en)
|
2008-10-16 |
2019-11-19 |
David Reed Helton |
Treatment of organophosphate exposure with ocinaplon
|
WO2010074753A1
(en)
*
|
2008-12-23 |
2010-07-01 |
Map Pharmaceuticals, Inc. |
Inhalation devices and related methods for administration of sedative hypnotic compounds
|
WO2010099217A1
(en)
|
2009-02-25 |
2010-09-02 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
WO2010122576A1
(en)
|
2009-04-20 |
2010-10-28 |
Matrix Laboratories Ltd |
Improved process for the preparation of 6-methyl-2-[4-methyl phenyl] imidazo [1, 2-a] pyridine-3-n, n-dimethyl acetamide.
|
JP5433508B2
(ja)
*
|
2009-06-25 |
2014-03-05 |
高田製薬株式会社 |
ゾルピデム酒石酸塩含有内用液剤
|
CN102234275B
(zh)
*
|
2010-04-27 |
2015-12-16 |
溧阳合誉药物科技有限公司 |
治疗失眠的氘代咪唑并[1,2-a]吡啶衍生物、制备方法及其应用
|
US8741888B2
(en)
|
2010-11-09 |
2014-06-03 |
Carl A. Forest |
Sleep aid composition and method
|
IN2013MU02428A
(no)
*
|
2013-07-22 |
2015-06-19 |
3A Chemie Private Ltd |
|
US10202376B2
(en)
|
2014-12-24 |
2019-02-12 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
EP3468545A4
(en)
|
2016-06-08 |
2020-07-22 |
President and Fellows of Harvard College |
METHODS AND COMPOSITIONS FOR REDUCING TACTILE DYSFUNCTION AND ANXIETY RELATED TO AUTISM SPECTRUM DISORDER, RETT SYNDROME AND FRAGILE X SYNDROME
|
AU2019241765B2
(en)
*
|
2018-03-28 |
2022-07-07 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound and use thereof
|
US11434244B2
(en)
|
2018-05-29 |
2022-09-06 |
President And Fellows Of Harvard College |
Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment
|
JP2021050161A
(ja)
|
2019-09-25 |
2021-04-01 |
武田薬品工業株式会社 |
複素環化合物及びその用途
|